Your dose may be too high for you, or a slower titration may help
In the N171-82Q transgenic mouse model, exendin-4 treatment improved motor function, prolonged survival, and reduced mutant huntingtin aggregation in the brain
The post lists pregnancy, severe renal impairment, and a personal or family history of medullary thyroid cancer as contraindications that apply to both the sublingual and the injected form
This guide covers cellular receptors and signaling pathways targeted by vision peptides, detailed mechanisms for specific peptides (BPC-157, Cerebrolysin, GHK-Cu, Thymosin Beta-4), understanding blood-retinal barrier penetration and peptide delivery challenges, gene expression changes induced by peptide treatment, comparing peptide mechanisms to conventional eye medications, dose-response relationships and optimal timing considerations, synergistic mechanisms when combining multiple peptides, and translating mechanistic understanding into practical treatment protocols